This inventor holds 1 USPTO granted patent. Top assignee: Sankyo Company, Limited. Active years: 1997.
Company Filing History:
Years Active: 1997
Title: Toru Komai: Innovator in Cholesterol Biosynthesis Inhibition
Introduction
Toru Komai is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of biochemistry, particularly in the area of cholesterol biosynthesis. His innovative work has implications for the treatment of diseases related to high blood cholesterol levels.
Latest Patents
Toru Komai holds a patent for "Octahydronaphthalene oxime derivatives for cholesterol biosynthesis." This patent describes compounds that have the ability to inhibit the biosynthesis of cholesterol. The compounds are characterized by a specific formula where R can be hydrogen, methyl, or hydroxy, and X can be various groups such as alkyl, alkenyl, cycloalkyl, aryl, aralkyl, or a heterocyclic group. These compounds can be utilized for the treatment and prophylaxis of diseases associated with high blood cholesterol levels. He has 1 patent to his name.
Career Highlights
Toru Komai is associated with Sankyo Company, Limited, where he has been able to apply his expertise in biochemistry. His work at the company has allowed him to focus on innovative solutions for health-related challenges.
Collaborations
Throughout his career, Toru has collaborated with esteemed colleagues such as Teiichiro Koga and Haruo Iwabuchi. These collaborations have contributed to the advancement of research in cholesterol biosynthesis and related fields.
Conclusion
Toru Komai's contributions to the field of cholesterol biosynthesis inhibition highlight his role as an important inventor in biochemistry. His innovative patent has the potential to impact the treatment of high blood cholesterol levels significantly.